News & Events

Learn about what's new with CMC Biologics

Trefoil Therapeutics Selects AGC Biologics as Lead Manufacturer of TTHX1114 for Treatment of Corneal Diseases


AGC Biologics Expands Plasmid DNA Offering


SEATTLE, December 11, 2019-- AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmaceuticals, is significantly expanding its CDMO services with plasmid DNA (pDNA) offerings from its Heidelberg site in Germany. With the demand for pDNA growing rapidly, AGC Biologics is leveraging 25 years of experience and comprehensive in-house analytics development to ensure customers short and dependable timelines.

BIO Japan October 14 - 16, 2020 in Yokohama, Japan


We hope to see you at BIO Japan in Yokohama, Japan on October 14 - 16, 2020.

CPhI Worldwide, October 13 - 15, 2020 in Milan, Italy


We're looking forward to attending cPHI in Milan, Italy.  

Will you be joining us there? Let us know if you'd like to meet. Email us at

BIO-Europe Spring March 23 - 25, 2020 in Paris, France


Engage with AGC Biologics at Europe’s largest springtime biotech partnering event.

Email us at to set up a meeting or contact us via our website and visit to register

BIO International Conference, June 8 - 11, 2020 in San Diego, CA


17,000+ attendees from around the globe will gather for BIO 2020.  This is a great opportunity for unparalleled partnering, education and networking.  Look for us in the BioProcess Zone, Booth 1111 in the San Diego Convention Center.


38th Annual J.P. Morgan Healthcare Conference  Jan 13-16,  2020 in San Francisco, CA



The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry.

In 2020 there will likely be 450+ companies, both public and private, delivering presentations to more than 9,000 attendees.

See you in San Francisco!

AGC Biologics’ $18m Investment in Seattle and Denmark Facilities Strengthens Global Footprint


SEATTLE, WA -- November 11th, 2019 -- AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today that their development and manufacturing capabilities at their Seattle, Washington and Copenhagen, Denmark facilities will be expanded, as part of an ongoing commitment to deliver the highest standard of service for their customers.

AGC Biologics Appoints New Site Head/General Manager  of Copenhagen, Denmark Operations


Jeffrey D. Mowery Named Site Head/General Manager

AGC Biologics Appoints New Site Head/General Manager  of Chiba, Japan Operations


Naofumi Kagami Named Site Head/General Manager

Follow Us
Join us on LinkedIn Follow us on Twitter